---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-077430"
form_type: "8-K"
ticker: "SGMT"
cik: "0001400118"
company_name: "Sagimet Biosciences Inc."
filed_at: "2024-07-02T23:59:59+00:00"
generated_at: "2026-05-31T23:44:28.774401+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "low"
source: SEC EDGAR
---

# Sagimet updates investor presentation; no material financial or clinical data changes

## Summary
- Company filed updated slide presentation for investor meetings dated July 2, 2024.
- Presentation covers pipeline programs in MASH, acne, and cancer.
- No specific new results, guidance, or material developments were disclosed.

## SEC filing metadata
- accession: 0001104659-24-077430
- form_type: 8-K
- ticker: SGMT
- cik: 0001400118
- company_name: Sagimet Biosciences Inc.
- filed_at: 2024-07-02T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: low
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1400118/000110465924077430/0001104659-24-077430-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1400118/000110465924077430/tm2418784d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-077430
- JSON: https://secwatch.observer/filing/0001104659-24-077430.json
- Plain text: https://secwatch.observer/filing/0001104659-24-077430.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.